Controversial TV physician Dr. Mehmet Oz hasn’t had a great year what with his disastrous testimony before Congress. (2020 Update; Dr. Oz recently had a good show on stem cell clinics so that’s something. I discussed issues with his staff prior to the show.) Now Dr. Oz has been slammed by a group doctors from […]
Doctors call for Dr. Oz to be booted from Columbia Read More »
I’m doing a series of interviews with leaders in the field on human germline modification with the first interview in this series with George Church and today’s second in this series is a conversation I had with Dr. Jennifer Doudna, a pioneer in CRISPR-Cas9 technology. Doudna is a Professor in MCB and Chemistry as well
Jennifer Doudna Interview on CRISPR, Human Gene Editing Read More »
The big stem cell news already this week is the acquisition by Fujifilm of Cellular Dynamics International (CDI) for a whopping $307 million dollars or about $16.50 per CDI share. You can read the press release here. Update: The entity is now known as Fujifilm Cellular Dynamics. It was less than two years ago that CDI did
Was Fujifilm CDI acquisition a good move by the companies? Read More »
By Jane Langille A few weeks ago, I wrote to Dr. Paul Knoepfler after reading his book Stem Cells: An Insider’s Guide because I was intrigued by his stem cell theory of aging. I wondered if his theory might mean that someone who mobilized and donated hematopoietic cells might be shortening their own lifetime supply. After
Risks for Healthy PBSC Donors? One Family’s Powerful Experience Read More »
You might enjoy the recommended reads below and find they surprise and educate you. Products in the pipeline – Ocata’s RPE by Alexey, a nice update on Ocata. Yes, we are seeing more attacks on academic freedom: guest post by historian of science and medicine. Guest piece by Alice Dreger on her new book, Galileo’s Middle Finger.
Weekend Reads from a Wild, Fun Week of Science Read More »
Here are some papers and news for weekend reads. What are you reading this weekend? What are your go-to stem cell journals? Hostile Takeover: Glioma Stem Cells Recruit TAMs to Support Tumor Progression by Yu Shi, Yi-fang Ping, Xia Zhang, Xiu-wu Bian in Cell Stem Cell. YAP1 Regulates OCT4 Activity and SOX2 Expression to Facilitate self-renewal and
Weekend Reads: Cool Papers, PubPeer, Jacob Hanna, & More Read More »
A question that has come up with advances in stem cell technology: could same-sex couples have their own biological children? Since Shinya Yamanaka reprogrammed first mouse and then human ordinary cells into powerful pluripotent stem cells, termed induced pluripotent stem (iPS) cells, back in 2006-2007 many new research avenues have opened up. The impossible suddenly
Are babies from same-sex couples possible? Read More »
The challenge to the WARF/Jamie Thomson patents/IP on human embryonic stem cells (hESC) is at an end. The US Supreme Court declined to hear the case. Earlier, the USPTO had turned down the challenge leading to a winding road in the courts. What do you all think of this stem cell IP challenge and the
Supreme Court Rejection of WARF hESC Patent Challenge Discussion Read More »
I’ve seen many crazy things over the years doing this blog including exploits of Haruko Obokata . There was the Moriguchi IPS cell fraud, the electric stem cell bra, the stem cell supermodel case, the stem cell soup No. 7 aphrodisiac, the STAP cell scandal….and the craziness goes on. Today there’s a new one that even
Haruko Obokata 小保方 晴子-like Game Character Conducts ‘Dangerous Research’ Read More »
A cool new paper is out in Stem Cell Reports describing long-term tumorigenicity of human induced pluripotent stem cells (IPSC or IPS cells). See graphical abstract. The potential tumorigenicity of IPSC is a major concern when teams around the world are translating IPSC technology to the bedside. Past studies including one from my own lab have
Lessons from New IPS Cell Study Showing Tumors Read More »